| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |